title: Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
authors.affiliation: Department of Medicine, Division of Cardiology, University of Utah, Salt Lake City, Utah 84132, USA.
authors.forename: D O
authors.initials: DO
authors.lastname: Taylor
authors.forename: M L
authors.initials: ML
authors.lastname: Barr
authors.forename: B M
authors.initials: BM
authors.lastname: Meiser
authors.forename: S M
authors.initials: SM
authors.lastname: Pham
authors.forename: R M
authors.initials: RM
authors.lastname: Mentzer
authors.forename: A L
authors.initials: AL
authors.lastname: Gass
mesh_terms: D002986:Clinical Trials as Topic; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004344:Drug Incompatibility; D004347:Drug Interactions; D016903:Drug Monitoring / Q000592:standards; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy; D016027:Heart Transplantation / Q000276:immunology* / Q000592:standards*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000097:blood / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D016559:Tacrolimus / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D016559:Tacrolimus